These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3702058)

  • 1. [Effect of S6472 and cefaclor on bacterial flora in adult human feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Jan; 39(1):177-246. PubMed ID: 3702058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
    Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of norfloxacin on bacterial flora in human feces].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T
    Jpn J Antibiot; 1987 Sep; 40(9):1584-616. PubMed ID: 3694785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cefminox on bacterial flora in human adult feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Apr; 39(4):909-57. PubMed ID: 3761549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged action preparation of cefaclor].
    Sakamoto T; Kawai S; Doi Y; Aita K; Sonoyama T; Nishimura K; Matsuda S; Ito M; Imagawa T; Yasuda M
    Jpn J Antibiot; 1985 Mar; 38(3):813-21. PubMed ID: 3897611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
    Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
    Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Absorption and excretion studies of S6472 (sustained release preparations of cefaclor)].
    Tateno M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):834-48. PubMed ID: 4032715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of ceftriaxone on bacterial flora in human feces].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1985 Oct; 38(10):2770-96. PubMed ID: 4078993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of KS-R1 (ampicillin suppository) and ampicillin oral dosing on fecal flora of children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Katabuchi Y; Sakata Y; Fujimoto T; Ono E; Nishiyama T
    Jpn J Antibiot; 1985 Apr; 38(4):1049-85. PubMed ID: 3849603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of BMY-28100 on bacterial flora in adult human feces].
    Motohiro T; Kawakami A; Sasaki H; Aramaki M; Sakata Y; Tominaga K; Yamashita F
    Jpn J Antibiot; 1990 Nov; 43(11):1898-913. PubMed ID: 2287057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of aztreonam on bacterial flora in human feces].
    Motohiro T; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T
    Jpn J Antibiot; 1985 Nov; 38(11):3387-413. PubMed ID: 4094070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
    Finegold SM; Ingram-Drake L; Gee R; Reinhardt J; Edelstein MA; MacDonald K; Wexler H
    Antimicrob Agents Chemother; 1987 Mar; 31(3):443-6. PubMed ID: 3579262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
    Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
    Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
    Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.